Delaware’s top court ruled in GSK’s favor in saying it will review the admissibility of expert evidence in an upcoming trial over possible cancer risks from its Zantac heartburn remedy
More Stories
God-washing: Fund fined for misleading clients about its ‘biblically responsible investing’ strategy
Regulators said Inspire Investments failed to meet the investment criteria it marketed, after a similar crackdown on “greenwashing” among ESG...
More investors bet on Trump Media’s ‘DJT’ stock to drop
Short selling of DJT stock has risen ahead of the lockup expiration on insider sales on Friday.
Apple’s iPhone 16 is selling better than the iPhone 15, says T-Mobile CEO
T-Mobile Chief Executive Mike Sievert says it’s “nonsense” that the iPhone 16 line’s preorder sales are underwhelming so far.
Trump proposes credit-card interest caps, but smart money still views him bank-friendly
The analyst community isn’t taking the former president’s proposal too seriously, and is instead looking at Trump’s bank-friendly first term...
After Fed rate cut, the next 6 months will be crucial for investors. Here’s why.
“There still are opportunities here,” Erik Aarts at Touchstone Investments said.
Fertility-benefits provider Progyny’s stock on track for biggest-ever decline after losing ‘significant’ client
Progyny Inc.’s stock tumbled 31% Thursday, to put it on track for its biggest-ever one-day decline, after the provider of...